Title:
クロモン腸内遊離製剤
Document Type and Number:
Japanese Patent JP4558207
Kind Code:
B2
Abstract:
Orally administered chromones have been found to be effective in the treatment of allergic conditions such as asthma, general food allergies, ulcerative colitis, atopic eczema, chronic urticaria, and irritable bowel syndrome if it is presented such that the respective chromone becomes bioavailable within ten minutes of exposure to an intestinal fluid.
Inventors:
Wigmore Alexander James
Application Number:
JP2000580621A
Publication Date:
October 06, 2010
Filing Date:
November 09, 1999
Export Citation:
Assignee:
TR Healthcare Limited
International Classes:
A61K31/352; A61K9/16; C07D311/22; A61K9/20; A61K9/48; A61K9/50; A61K45/00; A61K47/14; A61K47/38; A61P1/00; A61P1/06; A61P1/08; A61P9/00; A61P11/00; A61P11/06; A61P17/00; A61P25/06; A61P27/16; A61P37/00; A61P37/08
Domestic Patent References:
| JP60501559A | ||||
| JP5394038A |
Attorney, Agent or Firm:
Akira Okawa